MCID: CTR027
MIFTS: 27

Cataract-Glaucoma

Categories: Eye diseases, Rare diseases

Aliases & Classifications for Cataract-Glaucoma

MalaCards integrated aliases for Cataract-Glaucoma:

Name: Cataract-Glaucoma 52
Cataract-Glaucoma Syndrome 58

Characteristics:

Orphanet epidemiological data:

58
cataract-glaucoma syndrome
Inheritance: Autosomal dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal;

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 58  
Rare eye diseases


External Ids:

ICD10 via Orphanet 33 Q12.0
Orphanet 58 ORPHA162

Summaries for Cataract-Glaucoma

MalaCards based summary : Cataract-Glaucoma, also known as cataract-glaucoma syndrome, is related to cataract and microphthalmia. An important gene associated with Cataract-Glaucoma is PITX3 (Paired Like Homeodomain 3). The drugs Prednisone and Levofloxacin have been mentioned in the context of this disorder. Affiliated tissues include eye, kidney and testes, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Related Diseases for Cataract-Glaucoma

Graphical network of the top 20 diseases related to Cataract-Glaucoma:



Diseases related to Cataract-Glaucoma

Symptoms & Phenotypes for Cataract-Glaucoma

GenomeRNAi Phenotypes related to Cataract-Glaucoma according to GeneCards Suite gene sharing:

26 (show all 33)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-105 10.02 ATOH7 PITX3
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-139 10.02 PITX3
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-142 10.02 ATOH7
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-151 10.02 PITX3
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-156 10.02 ATOH7
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-168 10.02 PITX3
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-190 10.02 ATOH7
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-191 10.02 PITX3
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-216 10.02 OCRL
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-22 10.02 PITX3
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-43 10.02 ATOH7
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-59 10.02 ATOH7
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-65 10.02 PITX3
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-77 10.02 ATOH7 PITX3
15 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.6 OCRL
16 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.6 OCRL
17 Increased shRNA abundance (Z-score > 2) GR00366-A-152 9.6 OCRL
18 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.6 PITX3
19 Increased shRNA abundance (Z-score > 2) GR00366-A-172 9.6 PITX3
20 Increased shRNA abundance (Z-score > 2) GR00366-A-199 9.6 PITX3
21 Increased shRNA abundance (Z-score > 2) GR00366-A-213 9.6 PITX3
22 Increased shRNA abundance (Z-score > 2) GR00366-A-23 9.6 PITX3
23 Increased shRNA abundance (Z-score > 2) GR00366-A-40 9.6 PITX3
24 Increased shRNA abundance (Z-score > 2) GR00366-A-50 9.6 PITX3
25 Increased shRNA abundance (Z-score > 2) GR00366-A-59 9.6 OCRL
26 Increased shRNA abundance (Z-score > 2) GR00366-A-65 9.6 OCRL
27 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.6 OCRL
28 Increased shRNA abundance (Z-score > 2) GR00366-A-70 9.6 PITX3
29 Increased shRNA abundance (Z-score > 2) GR00366-A-82 9.6 OCRL
30 Increased shRNA abundance (Z-score > 2) GR00366-A-87 9.6 OCRL
31 Increased shRNA abundance (Z-score > 2) GR00366-A-92 9.6 PITX3
32 Increased shRNA abundance (Z-score > 2) GR00366-A-93 9.6 PITX3
33 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.6 PITX3

MGI Mouse Phenotypes related to Cataract-Glaucoma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 reproductive system MP:0005389 9.13 ATOH7 OCRL PITX3
2 vision/eye MP:0005391 8.8 ATOH7 OCRL PITX3

Drugs & Therapeutics for Cataract-Glaucoma

Drugs for Cataract-Glaucoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 65)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
2
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
3
Ofloxacin Approved Phase 4 82419-36-1 4583
4
Cefuroxime Approved Phase 4 55268-75-2 5479529 5361202
5
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
6
tannic acid Approved Phase 4 1401-55-4
7
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
8
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
9 Protective Agents Phase 4
10 Pharmaceutical Solutions Phase 4
11 Gastrointestinal Agents Phase 4
12 Neuroprotective Agents Phase 4
13 Antiemetics Phase 4
14 Anti-Bacterial Agents Phase 4
15 Antibiotics, Antitubercular Phase 4
16 Cytochrome P-450 Enzyme Inhibitors Phase 4
17 Anti-Infective Agents Phase 4
18 Ophthalmic Solutions Phase 4
19 Anesthetics Phase 4
20 cefuroxime axetil Phase 4
21
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
22
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
23
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
24 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
25
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
26
Pilocarpine Approved, Investigational Phase 3 54-71-7, 92-13-7 5910
27
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
28 Neurotransmitter Agents Phase 3
29 Hormones Phase 3
30 Hormone Antagonists Phase 3
31 glucocorticoids Phase 3
32 Anti-Inflammatory Agents Phase 3
33 Methylprednisolone Acetate Phase 3
34 Antineoplastic Agents, Hormonal Phase 3
35 Cholinergic Agents Phase 3
36 Muscarinic Agonists Phase 3
37
Bevacizumab Approved, Investigational Phase 2 216974-75-3
38 Mitogens Phase 2
39 Endothelial Growth Factors Phase 2
40 Angiogenesis Inhibitors Phase 2
41 Antineoplastic Agents, Immunological Phase 2
42 Adrenocorticotropic Hormone Phase 2
43 Melanocyte-Stimulating Hormones Phase 2
44 beta-Endorphin Phase 2
45 Endorphins Phase 2
46
Hyaluronic acid Approved, Vet_approved Phase 1 9004-61-9 53477741
47 Adjuvants, Immunologic Phase 1
48 Viscosupplements Phase 1
49 Immunologic Factors Phase 1
50
Fluticasone Approved, Experimental 90566-53-3 62924

Interventional clinical trials:

(show top 50) (show all 56)
# Name Status NCT ID Phase Drugs
1 Combined Phacoemulsification and Glaucoma Implant Surgery Versus Combined Phacoemulsification and Trabeculectomy: A Randomized Controlled Trial Unknown status NCT00273221 Phase 4
2 A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. Completed NCT00326014 Phase 4
3 A Comparison of Three Different Formulations of Topical Prednisolone Acetate 1% for Control of Post Glaucoma and/or Cataract Surgery Inflammation. Completed NCT00345046 Phase 4 Pred Forte;EconoPred Plus;Prednisolone Acetate
4 Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery Completed NCT00491049 Phase 4 0.5% levofloxacin eye drops
5 A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Active, not recruiting NCT01841450 Phase 4
6 A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent Not yet recruiting NCT03255785 Phase 4
7 Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for the Treatment of Open Angle Glaucoma in Patients With Cataract - a Randomised Controlled Trial Not yet recruiting NCT04295122 Phase 4
8 A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. Completed NCT00323284 Phase 3
9 A Prospective, Randomized, Controlled, Parallel Groupos, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 in Conjunction With Cataract Surgery Completed NCT01052558 Phase 3
10 A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Clinical Investigation Of The Trabecular Micro-Bypass Stent Model GTS400 In Conjunction With Cataract Surgery Completed NCT00721968 Phase 3
11 A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Trabectome Surgery Recruiting NCT04005079 Phase 3 Pilocarpine;Ofloxacin;Prednisolone
12 A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery Enrolling by invitation NCT03933631 Phase 3 Pilocarpine;Prednisolone;Ofloxacin
13 Evaluation of the Pain and Visual Outcome Associated With Location of Intravitreal Bevacizumab Injection Completed NCT02790775 Phase 2 Anti-VEGF in quadrant 1;Anti-VEGF in quadrant 2;Anti-VEGF in quadrant 3;Anti-VEGF in quadrant 4
14 A Prospective, Multi-Center Evaluation of the Hydrus Aqueous Implant (Standard and Low-Profile) for Lowering Intraocular Pressure (IOP) in Subjects With Mild to Advanced Primary Open Angle Glaucoma (POAG) With or Without a Cataract Completed NCT03065036 Phase 1, Phase 2 prestudy topical glaucoma medications
15 An Open Label, Multi-centered, Randomized Phase 2 Study to Evaluate the Safety, Tolerability and Bioactivity of Subcutaneous ACTH GeL in PAtients With Scleritis: The ATLAS Study Recruiting NCT03465111 Phase 2 ACTH (adrenocorticotropic hormone) gel
16 An Open Two-center Study Evaluating the Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy in Patients With Open Angle Glaucoma and Cataract Completed NCT01887873 Phase 1
17 Comparison of Safety and Efficacy of Three Variants of Canaloplasty: Ab-externo, Ab-interno and Minicanaloplasty Combined With Phacoemulsification to Treat Glaucoma and Cataract. A Randomised, Prospective Study. Unknown status NCT02908633
18 A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery Unknown status NCT01455467
19 Outcome of Small Pupil Phacotrabeculectomy in Persons With Glaucoma and Cataract Unknown status NCT00434707
20 To Check the Efficacy and Saftey of Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract Unknown status NCT02209961
21 Adrenocorticotrophic Hormone (ACTH) for the Treatment of Sarcoid Uveitis Unknown status NCT03473964 H.P. Acthar gel
22 Comparison of Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy Combined With Phacoemulsification to Treat Glaucoma and Cataract. A Randomised, Prospective Study. Unknown status NCT01726543
23 Frequency Of Eye Problems In Type 2 Diabetes With Chronic Kidney Disease Unknown status NCT03330054
24 To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation Unknown status NCT01023113
25 Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry Completed NCT01841437
26 Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) Completed NCT01332422 Salmeterol and Fluticasone
27 Effectiveness of Selective Laser Trabeculoplasty (SLT) After Failed Phacoemulsification Cataract Extraction Combined With Eximer Laser Trabeculectomy (Phaco-ELT) in Open Angle Glaucoma and Ocular Hypertension Completed NCT02434250
28 A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Newly Diagnosed Open Angle Glaucoma and Subjects Diagnosed With Ocular Hypertension Completed NCT00326066
29 A Prospective, Multi-Center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery. Completed NCT01818115
30 Comparison of Combined Phacotrabeculectomy and Trabeculectomy Only in the Treatment of Primary Angle-closure Glaucoma Completed NCT01298635
31 A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery Completed NCT02024464
32 A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery Completed NCT01085357
33 Longtime Efficiency of Combined Cataract-Surgery and Excimer-Laser-Trabeculotomy or Trabectome in Glaucoma Surgery Completed NCT01194310
34 Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma Completed NCT04430647
35 Comparison Between OCT Nerve Fiber Layer and Ganglion Cell Complex Parameters Following Cataract Extraction in Patients With or Without Primary Open Angle Glaucoma Completed NCT03889652
36 Study of the Safety and Effectiveness of the OculusGenTM Collagen Matrix Implant as an Aid in Phacotrabeculectomy Surgery Completed NCT00477685
37 Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients Completed NCT00707005
38 Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy Completed NCT00695747
39 A Novel Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma After Congenital Cataract Surgery Completed NCT03610295
40 A Randomized, Double-Masked Clinical Trial of Phacoemulsification Compared With Phacoemulsification and Micro-Bypass Stent Implantation in Patients With POAG Completed NCT00847158
41 Autoimmune Dysregulation in Pigmentary Glaucoma Completed NCT00280345
42 Lower Femtosecond Laser Energy Levels Lead to Better Visual Recovery After Small-incision Lenticule Extraction for Myopia Completed NCT03111160
43 Prospective, Multi‐Center, Post‐Market Study of Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma Recruiting NCT03861169
44 Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery Recruiting NCT04161963
45 A Randomised Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery With Insertion of iStent Inject® Recruiting NCT03106181
46 A Double-masked, Randomized, Cross-over Comparative Study of Novel Myopia Control Designed Lens (Test Lens) Versus Single Vision Lens (SVL; Control) Recruiting NCT04048148
47 Evaluation of the Xen Implant in Glaucoma Surgery Recruiting NCT03733600
48 Anterior Segment Changes Before and After Uneventful Combined Phaco-Trabeculectomy by Using Optical Coherence Tomography (OCT) Recruiting NCT03626675
49 A Prospective, Randomized, Multi-Center, Open-Label Trial Comparing a Novel Goniotomy Procedure and an Ab Interno Trabecular Bypass Device in the Treatment of Mild to Moderate Glaucoma in Patients Undergoing Cataract Extraction Active, not recruiting NCT02784249
50 A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery Active, not recruiting NCT01461291

Search NIH Clinical Center for Cataract-Glaucoma

Genetic Tests for Cataract-Glaucoma

Anatomical Context for Cataract-Glaucoma

MalaCards organs/tissues related to Cataract-Glaucoma:

40
Eye, Kidney, Testes, Endothelial

Publications for Cataract-Glaucoma

Articles related to Cataract-Glaucoma:

(show top 50) (show all 367)
# Title Authors PMID Year
1
Ocular complications and prophylactic strategies in Stickler syndrome: a systematic literature review. 61
32316871 2020
2
Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. 61
32541407 2020
3
Ophthalmologic Diseases in Kidney Transplant Recipients: A Single-Center Prospective Study. 61
32402454 2020
4
Biomarkers of inflammation and oxidative stress in ophthalmic disorders. 61
32046582 2020
5
Erratum to: Cataract, glaucoma, possible Marfan syndrome, and conception aspirations. 61
32358297 2020
6
High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases. 61
32331355 2020
7
Effect of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia following cataract surgery. 61
32221152 2020
8
Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance. 61
32012162 2020
9
[Capabilities of remote laser homeostasis of the conjunctiva and sclera]. 61
32366069 2020
10
Automated extraction of ophthalmic surgery outcomes from the electronic health record. 61
31706228 2020
11
[Prevalence of ophthalmic diseases in the population older than 50 years]. 61
32504485 2020
12
NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy. 61
32019187 2020
13
Wireless, passive strain sensor in a doughnut-shaped contact lens for continuous non-invasive self-monitoring of intraocular pressure. 61
31825423 2020
14
Consultation Section: Glaucoma. Cataract, glaucoma, possible Marfan syndrome, and conception aspirations. 61
32050248 2020
15
Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia. 61
32256044 2020
16
Long-term outcomes of penetrating keratoplasty for corneal complications of herpes zoster ophthalmicus. 61
30733209 2019
17
Hypotonia and delayed motor development as an early presentation of Lowe syndrome: case report and literature review. 61
30501482 2019
18
Biallelic Deletion of Pxdn in Mice Leads to Anophthalmia and Severe Eye Malformation. 61
31817535 2019
19
One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities. 61
31538316 2019
20
Relationship between refractive correction, visual symptoms, and optical device selection for low-vision patients in Taiwan. 61
31787520 2019
21
Complications and adverse events of plaque brachytherapy for ocular melanoma. 61
31523242 2019
22
Perioperative considerations and anesthesia management in patients with obstructive sleep apnea undergoing ophthalmic surgery. 61
31174989 2019
23
Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria. 61
31619898 2019
24
Relationships between Hearing Loss and the Prevalences of Cataract, Glaucoma, Diabetic Retinopathy, and Age-Related Macular Degeneration in Korea. 61
31336642 2019
25
Frequency of Ocular Diseases in Infants at a Tertiary Care Hospital. 61
31179661 2019
26
[Perioperative Anti-inflammatory Treatment in Glaucoma Surgery]. 61
31096283 2019
27
A rare cause of familial exogenous Cushing syndrome. 61
31198763 2019
28
Patient-oriented mobile applications in ophthalmology. 61
30168194 2019
29
Circular RNAs: Novel Promising Biomarkers in Ocular Diseases. 61
31171902 2019
30
Anterior chamber angle in aniridia with and without glaucoma. 61
31496636 2019
31
Outcomes of therapeutic keratoplasty for severe infectious keratitis in Chongqing, a 16-year experience. 61
31496763 2019
32
Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases. 61
30891116 2019
33
Magrabi ICO Cameroon Eye Institute, Yaoundé, Cameroon: Ophthalmology Subspecialty Patient Care and Training Center in Central Africa. 61
30240727 2019
34
[Features of the course of anterior uveitis associated with HLA-B27 antigen]. 61
31691649 2019
35
Pattern of Childhood Uveitis in Egypt. 61
30148647 2019
36
The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. 61
30774489 2019
37
[Who visits an ophthalmologist and how often? Results of the German nationwide adult health survey (DEGS1)]. 61
29110124 2018
38
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders. 61
30591791 2018
39
Evaluation of content and cost of traditional eye medication in a resource-poor country - Implications for eye care practice and policy. 61
30417853 2018
40
Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. 61
30176841 2018
41
Three-dimensional tubule formation assay as therapeutic screening model for ocular microvascular disorders. 61
29743587 2018
42
Ultraviolet radiation oxidative stress affects eye health. 61
29603665 2018
43
Comparison of outcomes and complications of deep anterior lamellar keratoplasty and penetrating keratoplasty performed in a large group of patients with keratoconus. 61
28534231 2018
44
Regenerating Eye Tissues to Preserve and Restore Vision. 61
29859174 2018
45
Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. 61
29699563 2018
46
Burden of vision loss associated with eye disease in China 1990-2020: findings from the Global Burden of Disease Study 2015. 61
28607177 2018
47
Projection of Eye Disease Burden in Singapore. 61
29493707 2018
48
Ophthalmological finding in a patient with lowe syndrome. 61
30650973 2018
49
Prevalence of visual impairment and related factors in Nangarhar Province of Afghanistan: a cross sectional study. 61
30588432 2018
50
Clinical Characteristics of Wolfram Syndrome in Chinese Population and a Novel Frameshift Mutation in WFS1. 61
29483894 2018

Variations for Cataract-Glaucoma

Expression for Cataract-Glaucoma

Search GEO for disease gene expression data for Cataract-Glaucoma.

Pathways for Cataract-Glaucoma

GO Terms for Cataract-Glaucoma

Sources for Cataract-Glaucoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....